The absence of an official, credible source of information or support platform for LC patients may prolong or worsen their symptoms and contribute to psychological distress due to a lack of timely guidance (15)
Oral GLP-1: May produce milder but more consistent symptoms due to daily dosing
The increased risk was seen even after accounting for reflux disease, which is already known to be more common on GLP 1 drugs
Tackling persistent fat deposits in specific areas has never been more exciting
The Treatment Imperative: Effectively managing obesity is now recognized as a primary strategy to curb the rise of T2D and its life-threatening complications
doi:10.3390/molecules191119066 Cerovecki T, Bojanic I, Brcic L, Radic B, Vukoja I, Seiwerth S, Sikiric P